Home > Insider Trading > Filing (0001062993-24-011556)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1205922	Vaccinex Inc.	VCNX	Pharmaceutical Preparations (2834)	161603202

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1268239	Albert Friedberg	220 Bay Street Suite 600 Toronto A6 M5J 2W4		Yes	No	Yes	No
1678258	Fcmi Parent Co.	220 Bay Street Suite 600 Toronto A6 M5J 2W4		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-05-29	957	$4.95	561,554	No	4	P	Indirect	By FCMI Parent Co.
Common Stock	Acquisiton	2024-05-30	861	$5.20	562,415	No	4	P	Indirect	By FCMI Parent Co.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By FCMI Parent Co.
No	4	P	Indirect	By FCMI Parent Co.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,094	Direct
Common Stock	180	Indirect	By Pan Atlantic Holdings Ltd.
Common Stock	16,724	Indirect	By Friedberg Global-Macro Hedge Fund Ltd.

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Warrant (Right to Buy)	$7.64	2024-03-28	2029-03-28	102,960	102,960	Indirect
Common Stock	Warrant (Right to Buy)	$14.00	2024-02-08	2029-02-08	118,226	118,226	Indirect
Common Stock	Warrant (Right to Buy)	$14.00	2023-10-03	2028-10-03	214,285	214,285	Indirect

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2029-03-28	102,960	102,960	Indirect
2029-02-08	118,226	118,226	Indirect
2028-10-03	214,285	214,285	Indirect

Footnotes

Mr. Friedberg is the majority owner of Pan Atlantic Holdings Ltd. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.17 to $5.20. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.